...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

I have e-trade, mine were recently valued at $0.475 and were shown as being recently traded(not my shares, but shares of ZHCLF).  I tried to buy more via e-trade and was denied.  TD Waterhouse also denied my friend to buy.

Share
New Message
Please login to post a reply